Lehman Brothers UK Capital Funding IV LP: Notice to the Holders of the Preferred Securities
September 19, 2024 08:12 ET
|
Lehman Brothers UK Capital Funding IV LP
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: EUR 200,000,000 EURO FIXED RATE ENHANCED CAPITAL ADVANTAGED PREFERRED SECURITIES ("LP IV ECAPS") ISSUER: LEHMAN BROTHERS...
Lehman Brothers UK Capital Funding V LP: Notice to the Holders of the Preferred Securities
September 19, 2024 08:10 ET
|
Lehman Brothers UK Capital Funding V LP
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: USD 500,000,000 FIXED RATE ENHANCED CAPITAL ADVANTAGED PREFERRED SECURITIES ("LP V ECAPS") ISSUER: LEHMAN BROTHERS UK CAPITAL...
Lehman Brothers UK Capital Funding LP: Notice to the Holders of the Preferred Securities
September 19, 2024 08:08 ET
|
Lehman Brothers UK Capital Funding LP
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: EUR 225,000,000 FIXED RATE TO CMS-LINKED GUARANTEED NON-VOTING, NON-CUMULATIVE PERPETUAL PREFERRED SECURITIES ("LP I...
NobleAI Recognized in Gartner’s Market Guide for Materials Informatics Solutions
September 19, 2024 08:05 ET
|
NobleAI
Gartner Report Highlights Company’s Strength and Unique Offering in Emerging AI for Science Sector
Filevine’s LEX Summit 2024: A Landmark Event for the Legal Industry
September 19, 2024 08:05 ET
|
Filevine
Salt Lake City, UT, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Filevine, leading provider of legal technology, successfully concluded its celebrated user conference, LEX Summit, held at the Hyatt Regency...
32BJ Labor Industry Cooperation Fund Releases Interactive Tools to Help Employers and Unions Achieve Lower Hospital Prices
September 19, 2024 08:02 ET
|
32BJ Labor Industry Cooperation Fund
To help purchasers/employers lower healthcare costs, the 32BJ Labor Industry Cooperation Fund released a hospital savings calculator and contract template.
Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors
September 19, 2024 08:00 ET
|
Eyconis, Inc.
REDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Eyconis, Inc., a biopharmaceutical company focused on developing novel, best-in-class therapeutics for eye diseases, today announced that...
Kaskela Law LLC Announces Shareholder Investigation of The Scotts Miracle-Gro Company (NYSE: SMG) and Encourages Long-Term SMG Shareholders to Contact the Firm
September 19, 2024 08:00 ET
|
Kaskela Law
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating The Scotts Miracle-Gro Company (NYSE: SMG) (“Scotts”) on behalf of the company’s long-term...
LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options
September 19, 2024 08:00 ET
|
LifeMD, Inc.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc.® (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced significant enhancements to its weight management...
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
September 19, 2024 08:00 ET
|
AIM ImmunoTech Inc.
Preliminary finding of stable disease in two out of three patients at 6 months in the first subject cohort Combination of Ampligen and Imfinzi continues to be generally well-tolerated with no...